ebomi
Colour theme
Sign in
Insider · CIK 0001250274

Israel Robert J

CIK 0001250274 Name as filed on the most recent filing

Filed as Israel Robert J (69)

89 transaction lines · from 69 filings · filed 2004-03-03 to 2015-06-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

89 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2015-06-11 S, Open-market sale Progenics Pharmaceuticals IncPGNX 13,660, disposed Open Form 4 filing 0001447348-15-000036
2015-03-13 S, Open-market sale Progenics Pharmaceuticals IncPGNX 21,000, disposed Open Form 4 filing 0001447348-15-000020
2015-03-11 S, Open-market sale Progenics Pharmaceuticals IncPGNX 13,660, disposed Open Form 4 filing 0001447348-15-000018
2015-03-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 32,450, disposed Open Form 4 filing 0001447348-15-000016
2015-01-12 S, Open-market sale Progenics Pharmaceuticals IncPGNX 14,112, disposed Open Form 4 filing 0001447348-15-000002
2014-12-11 S, Open-market sale Progenics Pharmaceuticals IncPGNX 21,201, disposed Open Form 4 filing 0001447348-14-000036
2014-11-21 S, Open-market sale Progenics Pharmaceuticals IncPGNX 63,000, disposed Open Form 4 filing 0001447348-14-000034
2014-11-13 S, Open-market sale Progenics Pharmaceuticals IncPGNX 68,300, disposed Open Form 4 filing 0001447348-14-000032
2014-11-11 S, Open-market sale Progenics Pharmaceuticals IncPGNX 32,650, disposed Open Form 4 filing 0001447348-14-000030
2013-07-18 S, Open-market sale Progenics Pharmaceuticals IncPGNX 31,650, disposed Open Form 4 filing 0001447348-13-000031
2012-07-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 9,790, disposed Open Form 4 filing 0001447348-12-000040
2012-06-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 8,508, disposed Open Form 4 filing 0001447348-12-000028
2012-05-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 10,927, disposed Open Form 4 filing 0001447348-12-000025
2012-04-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 9,852, disposed Open Form 4 filing 0001447348-12-000022
2012-03-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 9,817, disposed Open Form 4 filing 0001447348-12-000013
2012-02-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 9,478, disposed Open Form 4 filing 0001447348-12-000005
2012-01-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 8,780, disposed Open Form 4 filing 0001447348-12-000002
2011-12-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 6,660, disposed Open Form 4 filing 0001447348-11-000020
2011-11-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 6,330, disposed Open Form 4 filing 0001447348-11-000017
2011-10-05 S, Open-market sale Progenics Pharmaceuticals IncPGNX 6,330, disposed Open Form 4 filing 0001447348-11-000015
2011-09-27 S, Open-market sale Progenics Pharmaceuticals IncPGNX 4,722, disposed Open Form 4 filing 0001447348-11-000011
2011-09-20 S, Open-market sale Progenics Pharmaceuticals IncPGNX 633, disposed Open Form 4 filing 0001447348-11-000009
2011-09-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 975, disposed Open Form 4 filing 0001266375-11-000006
2011-08-11 S, Open-market sale Progenics Pharmaceuticals IncPGNX 6,330, disposed Open Form 4 filing 0001266375-11-000004
2011-07-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 7,205, disposed Open Form 4 filing 0001441844-11-000028
2011-06-21 S, Open-market sale Progenics Pharmaceuticals IncPGNX 55,341, disposed Open Form 4 filing 0001441844-11-000025
2011-06-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 8,153, disposed Open Form 4 filing 0001441844-11-000020
2011-05-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 7,390, disposed Open Form 4 filing 0001441844-11-000018
2011-04-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 6,330, disposed Open Form 4 filing 0001441844-11-000013
2011-03-29 S, Open-market sale Progenics Pharmaceuticals IncPGNX 5,064, disposed Open Form 4 filing 0001441844-11-000012
2011-03-08 S, Open-market sale Progenics Pharmaceuticals IncPGNX 1,266, disposed Open Form 4 filing 0001441844-11-000008
2011-02-07 S, Open-market sale Progenics Pharmaceuticals IncPGNX 48,089, disposed Open Form 4 filing 0001441844-11-000006
2011-01-19 S, Open-market sale Progenics Pharmaceuticals IncPGNX 2,551, disposed Open Form 4 filing 0001441844-11-000005
2010-06-22 S, Open-market sale Progenics Pharmaceuticals IncPGNX 35,961, disposed Open Form 4 filing 0001441844-10-000039
2010-03-18 S, Open-market sale Progenics Pharmaceuticals IncPGNX 37,891, disposed Open Form 4 filing 0001441844-10-000015
2008-09-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 15,000, disposed Open Form 4 filing 0001441844-08-000005
2008-08-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 16,465, disposed Open Form 4 filing 0001441844-08-000002
2008-07-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 15,592, disposed Open Form 4 filing 0001432664-08-000003
2008-06-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 16,397, disposed Open Form 4 filing 0001266375-08-000024
2008-05-27 S, Open-market sale Progenics Pharmaceuticals IncPGNX 15,000, disposed Open Form 4 filing 0001266375-08-000023
2008-04-25 S, Open-market sale Progenics Pharmaceuticals IncPGNX 15,000, disposed Open Form 4 filing 0001266375-08-000020
2008-03-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 15,300, disposed Open Form 4 filing 0001266375-08-000011
2008-02-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 16,440, disposed Open Form 4 filing 0001266375-08-000010
2008-01-02 S, Open-market sale Progenics Pharmaceuticals IncPGNX 18,120, disposed Open Form 4 filing 0001266375-08-000006
2007-12-06 S, Open-market sale Progenics Pharmaceuticals IncPGNX 20,000, disposed Open Form 4 filing 0001266375-07-000080
2007-12-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 19,239, disposed Open Form 4 filing 0001266375-07-000079
2006-12-04 S, Open-market sale Progenics Pharmaceuticals IncPGNX 140,000, disposed Open Form 4 filing 0001266375-06-000111
2006-12-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 134,565, disposed Open Form 4 filing 0001266375-06-000110
2006-11-10 S, Open-market sale Progenics Pharmaceuticals IncPGNX 140,000, disposed Open Form 4 filing 0001266375-06-000103
2006-11-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 129,820, disposed Open Form 4 filing 0001266375-06-000101

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 89
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. ISRAEL ROBERT J, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001250274

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.